A virtual event dedicated to transcatheter treatment strategies for coronary and structural heart disease

Overview

Radcliffe Cardiology is delighted to announce that Transcatheter Interventions Online (TIO) will return on 9–12 April 2025.

Over five hugely successful years, TIO has established itself as a leading virtual event serving the educational needs of the global interventional cardiology community.

Under the guidance of Course Director, Prof Nicolas Van Mieghem (Erasmus MC, Rotterdam, NL), TIO brings together a faculty of international renown, case centres of excellence and a global audience of thousands of HCPs, for education that is both authoritative and enduring in support of superior patient outcomes.

With a mix of live cases, practical tips and tricks, insightful presentations and debate, this CME-accredited event will again be carefully curated to enhance knowledge, address practical challenges and explore innovative solutions in real-world settings.

Due to demand from our attendees, this year’s programme has been extended to four days. The first three days will maintain a global outlook, with faculty and case centres selected to represent and resonate with our truly international audience. The new fourth day will be TIO 2025 I US Focus – dedicated to the challenges of US-based practice.

With a reach that is truly global – in 2024, over 2,500 healthcare professionals from 155 countries joined for CME-accredited best-in-class education – TIO 2025 promises to be larger still.

Whatever your geographical location of practice, TIO 2025 is here to support your endeavour to achieve optimum outcomes in clinical practice.

Register now to join thousands of HCPs worldwide at TIO 2025.

Join the conversation - #TIOCongress2025

*Transcatheter Interventions Online 2025's programme will be submitted to the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 11 CME points, equating to 11 hours of effective education time. Physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™.

Event starts in:

Share this event:

Course Leadership

Nicolas Van Mieghem

Nicolas Van Mieghem
Course Director
Thoraxcenter, Erasmus MC, Rotterdam, NL

more info

Kendra Grubb

Kendra Grubb
Course co-director
Emory University, Atlanta, GE, US

more info

David Hildick-Smith

David Hildick-Smith
Course co-director
Sussex Cardiac Centre, Brighton and Sussex University Hospitals, Brighton, UK

more info

Roxana Mehran

Roxana Mehran
Course co-director
The Mount Sinai Hospital, New York, NY, US

more info

Holger Thiele

Holger Thiele
Course co-director
Leipzig Heart Hospital, Leipzig, DE

more info

Ajay Kirtane

Ajay Kirtane
Course co-director
Columbia University Medical Center and New York-Presbyterian Hospital, New York, NY, US

more info

Learning Objectives

Following the activities, participants will be able to:

  • Review planning and valve selection strategies in patients with prior valve failure
  • Summarise recent repair and replacement data in mitral and tricuspid regurgitation
  • Select suitable tools for undertaking PCI in calcified lesions
  • Optimise use of imaging in daily practice
  • Outline the pros and cons of using P2Y12 inhibitors universally following PCI
  • Identify situations where an IVUS or OCT-guided approach are preferable
  • Discuss the possible implications of TAVR becoming a care option in asymptomatic aortic stenosis

Target Audience

  • Interventional Cardiologists
  • Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
  • Interventional Cardiology Nurses

If you’re interested in becoming an educational partner at TIO, please contact sales@radcliffe-group.com

Official Journal

Interventional Cardiology: Reviews, Research, Resources (ICR³) is an international, English language, peer-reviewed journal that publishes articles continuously on ICRjournal.com. It aims to assist time-pressured physicians to stay abreast of key advances and opinions in interventional cardiology.

Led by Editor-in-Chief Peter O'Kane, along with Deputy Editors and an editorial board of world-renowned physicians, the journal publishes peer-reviewed articles that aim to provide timely updates on the most pertinent issues in the field.

View the 2024 volume of ICR3

About Radcliffe Cardiology

We are Radcliffe, a knowledge network for the cardiovascular community

We’re here to bring cardiovascular knowledge, insight and innovation to life for clinicians around the world, using our communications and creative expertise, our platforms and connections across the community to help transform theory into practice faster and more effectively.

We bring medical knowledge to life

From great science writing and smart journal editing, the curation of evidence based and peer-reviewed content, to engaging new formats that cut through the noise, we believe that communication is at the heart of great healthcare.

Our work is underpinned by 3 core principles:

  • We build on the best science
  • We work hands-on with our community
  • We bring fresh thinking


Our promise is that we’ll equip you with the latest knowledge and skills you need, to do the best for your patients.

For more information on Radcliffe Cardiology, please visit www.radcliffecardiology.com